Latest News
Boston-based private equity firm Bunker Hill Capital has sold its portfolio company, The Smith & Wollensky Restaurant Group (SWRG) to Danu Partners, a private investment firm based in Ireland and a sub-licensee of SWRG which opened a restaurant in London in June, 2015.
David Jacquin, Founder and Managing Director of North Point Advisors, advised Bunker Hill Capital and SWRG on the sale.
Mark DeBlois, a Managing Partner of Bunker Hill Capital, says: “It has been our privilege to work with SWRG CEO Mike Feighery and his team in opening two new locations at Atlantic Wharf, Boston and in London with
Adarza BioSystems has closed a USD5 million Series B financing. Proceeds from the financing will be used to expand production capacity in its St Peters, MO manufacturing facility and launch its first immunoassay product consumable and instrument platform.
Proceeds will also be used to accelerate development of highly sensitive assays targeting a variety of biological analytes including cytokines, antigens and small molecules. Adarza’s Arrayed Imaging Reflectometry (AIR-StripTM) will bring an unprecedented combination of performance, workflow benefits with high sensitivity, broad dynamic range, precision, assay robustness to both life science and drug development researchers as well as clinical diagnostics practitioners.
Sverica Capital Management has held the final close of its fourth private equity fund, Sverica Capital Partners Fund IV LP, which exceeded its original target, was oversubscribed and closed at its hard cap of USD275 million.
Sverica will use Fund IV to continue its strategy of investing in growing business and IT services, healthcare services and high value industrial companies that have the potential to be category leaders in their respective industries.
Dave Finley, Managing Director of Sverica, says: “We appreciate the strong support shown for Fund IV from new and key existing investors. We believe the fundraise validates Sverica’s
Spectral Edge has completed an oversubscribed GBP1.5 million second funding round. New lead investors IQ Capital and Parkwalk Advisors, along with angel investors from Cambridge Angels, Wren Capital, Cambridge Capital Group and Martlet, the Marshall of Cambridge Corporate Angel investment fund, join the Rainbow Seed Fund/Midven and Iceni in backing the company.
Spun out of the University of East Anglia (UEA) Colour Lab, Spectral Edge has developed innovative image fusion technology. This combines different types of image, ranging from the visible to invisible (such as infrared and thermal), to enhance detail, aid visual accessibility, and create ever more beautiful pictures.
Gimv today announces a EUR 4 million investment in Topas Therapeutics, a biopharma company developing a unique immunotherapy approach to treat autoimmune diseases.
This investment is part of a total Series A financing round of EUR 14 million from a consortium of specialised life sciences investors including Epidarex Capital, EMBL Ventures and Evotec AG.
Topas Therapeutics, based in Hamburg (Germany), has developed a unique technology for the induction of antigen-specific immune tolerance. This new approach has the potential to treat autoimmune diseases, allergies and drug induced immune reactions in a more efficient and safe way. The funds will be used
CMS’s 8th annual M&A Study predicts an uncertain year despite the record levels of deal value in 2015. In the study, CMS analyses over 2,000 of its non-listed European public and private company deals between 2010 and 2015.
The uncertainty is attributed to a number of grey or black swan events including the long predicted slowdown of China’s economic growth and the greatest migration to Europe for a century across a fragile Schengen zone. The report also indicates that US interest rates and the clampdown on inversion deals, the divisive US election, a more aggressive corporate tax climate and the
NVM Private Equity (NVM) has appointed Charles Winward to its investment team. Winward will be responsible for sourcing, transacting and managing VCT investments.
Winward was previously a director at IP Group plc, where he was the Managing Director of its fund management and advisory subsidiary. Over seven years at IP Group (during which time they moved from AIM to the FTSE 250), he assisted in creating and developing several spin-out technology companies from university intellectual property, with notable successes being Tracsis plc (University of Leeds), Xeros Technology plc (University of Leeds), Boxarr Limited (Universities of Southampton and Bristol) and hVivo
Private debt specialist Old Hill Partners has appointed former GE Capital executive Shila Ray as Financial Officer.
Ray will be responsible for overall finance and fund accounting functions at the company and has been named to the firm's investment committee. Ray has over 20 years of experience in finance leadership roles. He served as CFO and in various global leadership positions for businesses within GE Capital. He has extensive experience in scaling up enterprises and has been instrumental in leading the finance function for various global and domestic operations. After GE Capital, Shila served as CFO of an alternative finance
Asure Software has acquired Mangrove Employer Services, a Tampa, Florida-based cloud SaaS vendor in Human Capital Management (HCM) applications.
The company develops, and implements HR, Payroll, Benefits, and Talent Management software solutions. Mangrove’s HCM suite of solutions is designed to be easy-to-use, with fully integrated HR/payroll applications to help companies recruit, manage, pay, and analyse their workforce more effectively.
The acquisition enables Asure Software to alter the marketplace of Human Capital Management by offering a comprehensive solution that brings workforce and workspace management together. These two workflows combined in one unified management platform increases company bottom-line performance through greater employee
AITV, a US-based venture capital firm that invests in early-stage and medium-growth software companies, has made a follow-on investment in LiveAction's recent USD36 million Series B financing, alongside Insight Venture Partners and Cisco Investments.
As part of the investment, founding general partner, Bill Malloy, joins the LiveAction board as an observer, alongside already presiding board member and founding general partner, Brian Nugent. The funding proceeds will allow LiveAction to focus on expanding operations globally and accelerate feature product development, further establishing the company as the visibility software standard for the Forbes Global 2000.
"Our follow-on capital into LiveAction not only
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
